Bank of Nova Scotia Trust’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-17,133
| Closed | -$932K | – | 133 |
|
|
2022
Q2 | $932K | Sell |
17,133
-148
| -0.9% | -$8.05K | 0.1% | 77 |
|
|
2022
Q1 | $941K | Buy |
17,281
+175
| +1% | +$9.53K | 0.08% | 81 |
|
|
2021
Q4 | $943K | Sell |
17,106
-218
| -1% | -$12K | 0.08% | 83 |
|
|
2021
Q3 | $827K | Buy |
17,324
+6
| +0% | +$286 | 0.07% | 84 |
|
|
2021
Q2 | $862K | Sell |
17,318
-1,206
| -7% | -$60K | 0.08% | 82 |
|
|
2021
Q1 | $826K | Buy |
18,524
+24
| +0.1% | +$1.07K | 0.08% | 80 |
|
|
2020
Q4 | $851K | Sell |
18,500
-34
| -0.2% | -$1.56K | 0.09% | 76 |
|
|
2020
Q3 | $872K | Buy |
18,534
+78
| +0.4% | +$3.67K | 0.11% | 70 |
|
|
2020
Q2 | $941K | Buy |
+18,456
| New | +$941K | 0.14% | 62 |
|
|
2017
Q4 | – | Sell |
-5,052
| Closed | -$256K | – | 235 |
|
|
2017
Q3 | $256K | Buy |
5,052
+741
| +17% | +$37.5K | 0.03% | 124 |
|
|
2017
Q2 | $232K | Sell |
4,311
-32
| -0.7% | -$1.72K | 0.03% | 115 |
|
|
2017
Q1 | $229K | Buy |
+4,343
| New | +$229K | 0.03% | 112 |
|